Treatment of Tinea Capitis

Organism-Directed First-Line Therapy

• The British Journal of Dermatology recommends terbinafine as the preferred first-line agent for Trichophyton species infections due to its fungicidal activity and superior efficacy, with a treatment duration of 2-4 weeks 1
• The British Journal of Dermatology suggests that griseofulvin is the preferred first-line agent for Microsporum species infections, with a treatment duration of 6-8 weeks 1
• The advantages of terbinafine include a shorter treatment duration, which improves compliance, with gastrointestinal disturbances and rashes occurring in less than 8% of children 1
• The British Journal of Dermatology notes that terbinafine fails against Microsporum species because it cannot be incorporated into hair shafts in prepubertal children and doesn't reach the scalp surface where arthroconidia are located 1
• The British Journal of Dermatology recommends that 8 weeks of griseofulvin is significantly more effective than 4 weeks of terbinafine for confirmed Microsporum infection 1

When to Start Treatment Empirically

• The British Journal of Dermatology suggests starting treatment before mycology results if any cardinal clinical signs are present, such as scale, lymphadenopathy, alopecia, or kerion 1
• The British Journal of Dermatology recommends collecting specimens via scalp scrapings, hair pluck, brush, or swab for microscopy and culture, and notes that oral therapy is required for both clinical and mycological cure 1

Second-Line Options for Treatment Failure

• The British Journal of Dermatology recommends considering factors such as poor compliance, suboptimal drug absorption, organism insensitivity, or reinfection if initial therapy fails 1
• The British Journal of Dermatology suggests continuing current therapy for an additional 2-4 weeks if clinical improvement but positive mycology persists, and switching to second-line therapy if no clinical improvement occurs 1

Common Pitfalls to Avoid

• The British Journal of Dermatology advises against using terbinafine for Microsporum infections due to its poor efficacy, and against relying on topical therapy alone as it cannot eradicate scalp infections 1
• The British Journal of Dermatology recommends avoiding underdosing griseofulvin, as higher doses are needed due to increasing treatment failures with lower doses 1

Treatment of Tinea Capitis

Diagnostic Approach

• The British Journal of Dermatology recommends collecting scalp samples via scrapings, hair pluck, brush or swab for microscopy and culture to confirm infection and identify the causative organism, with microscopy using potassium hydroxide providing rapid preliminary diagnosis 2

First-Line Treatment Options

• The British Journal of Dermatology states that griseofulvin is the only licensed treatment for tinea capitis in children in many countries, with dosing of 15-20 mg/kg/day for 6-8 weeks in children under 50 kg and 1 g/day for 6-8 weeks in children over 50 kg and adults 3, 2
• The British Journal of Dermatology recommends terbinafine as a first-line treatment option, with weight-based dosing of 62.5 mg/day for 2-4 weeks in children under 20 kg, 125 mg/day for 2-4 weeks in children between 20-40 kg, and 250 mg/day for 2-4 weeks in children over 40 kg 3, 4

Second-Line Treatment

• The British Journal of Dermatology suggests itraconazole as a second-line treatment option, with dosing of 5 mg/kg/day for 2-4 weeks or 50-100 mg/day for 4 weeks, effective against both Trichophyton and Microsporum species 3, 4
• The British Journal of Dermatology recommends fluconazole as an alternative for refractory cases, with a favorable tolerability profile and availability in liquid form 3, 4

Treatment Algorithm

• The British Journal of Dermatology advises identifying the causative organism through microscopy and culture, and selecting antifungal based on species, with terbinafine as first choice for Trichophyton species and griseofulvin as first choice for Microsporum species 3, 4, 2

Adjunctive Measures

• The British Journal of Dermatology recommends topical therapy as an adjunctive treatment, and screening and treating family members and close contacts, especially for T. tonsurans infections 3, 4

Monitoring and Follow-up

• The British Journal of Dermatology states that treatment endpoint is mycological cure, not just clinical improvement, and recommends repeat mycology sampling until clearance is achieved, and monitoring for treatment side effects 3, 4

Treatment of Scalp Ringworm (Tinea Capitis) in Pediatric Patients

First-Line Treatment Selection Based on Organism

• The British Journal of Dermatology recommends oral antifungal therapy as mandatory for tinea capitis, with topical therapy alone being ineffective and should never be used as monotherapy 5

Critical Treatment Principles

• The endpoint of treatment is mycological cure, not clinical improvement, and repeat mycology sampling is mandatory until clearance is achieved, as recommended by the British Journal of Dermatology 5

Adjunctive Measures

• The British Journal of Dermatology suggests that topical antifungal therapy should be used as adjunctive treatment only, and screening of all family members and close contacts is necessary, especially for T. tonsurans infections 5
• Cleansing hairbrushes and combs with bleach or 2% sodium hypochlorite solution is recommended by the British Journal of Dermatology 5

School Attendance

• Children receiving appropriate systemic and adjunctive topical therapy can attend school or nursery, as exclusion is impractical and unnecessary, according to the British Journal of Dermatology 5

Second-Line Options for Treatment Failure

• The British Journal of Dermatology recommends second-line agents, including itraconazole and fluconazole, for treatment failure, with itraconazole effective against both Trichophyton and Microsporum species 5

Diagnostic and Management Guidelines for Tinea Capitis (Cited Evidence)

Diagnostic Specimen Collection

• Obtain mycological specimens before initiating therapy by using scalp scrapings, hair plucking, cytobrush (brush) sampling, or gauze swabs to maximize organism recovery. [6][7]

Ancillary Diagnostic Tools

• Perform Wood’s lamp examination to detect Microsporum canis infections, which exhibit characteristic fluorescence under ultraviolet light. 6
• Use dermoscopy as an adjunctive tool: “comma‑shaped” hairs are typical in white children with ectothrix infections, whereas corkscrew hairs are more common in Afro‑Caribbean children. 6

Kerion (Inflammatory Variant) Management

• Initiate oral systemic antifungal therapy immediately when a kerion is identified, without awaiting culture results. 6
• Add topical or oral corticosteroids to alleviate severe inflammatory symptoms associated with kerion. 6
• Recognize that kerion is a fungal‑driven inflammatory response, not a primary bacterial abscess; however, evaluate for secondary bacterial infection when clinically indicated. 6

Dermatophytid (Id) Reaction Management

• Understand that pruritic papular eruptions appearing after antifungal initiation represent a cell‑mediated response to dying dermatophytes and do not require discontinuation of systemic therapy. 6
• Provide symptomatic relief with topical corticosteroids (or oral steroids in severe cases) while continuing the antifungal regimen. 6

Favus (Chronic Variant) Characteristics

• Identify favus as a chronic inflammatory form of tinea capitis most often caused by Trichophyton schoenleinii. 6
• Recognize the hallmark yellow, cup‑shaped crusted lesions (“scutula”) that can lead to scarring (cicatricial) alopecia if untreated. 6
• Confirm diagnosis by noting the characteristic fluorescence of favus lesions under Wood’s lamp examination. 6